Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 3/20 | 0.47 |
| ▸ | CA1 known ✓ | P00915 | 3/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | FABP3 | P05413 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3114520 | 1.00 | GPR84 (0.54) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL1239366 | 1.00 | GPR84 (0.54) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL1239361 | 1.00 | GPR84 (0.54) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL29728786 | 1.00 | GPR84 (0.54) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL28788662 | 1.00 | GPR84 (0.54) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL438050 | 0.98 | GPR84 (0.51) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL438053 | 0.98 | GPR84 (0.51) | GPR84CA2NFKB1CA1NOD1 | |
| Potassium Ion SCHEMBL29518532 | 0.97 | GPR84 (0.50) | GPR84CA2NFKB1CA1NOD1 | |
| Potassium Ion SCHEMBL30514358 | 0.97 | GPR84 (0.50) | GPR84CA2NFKB1CA1NOD1 | |
| SCHEMBL8652553 | 0.95 | GPR84 (0.47) | GPR84CA2NFKB1CA1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4017467-B1 | COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN | BEIERSDORF AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4727519-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM AND VANILLIN DERIVATIVES | Beiersdorf AG (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4727521-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM AND ACETATES | Beiersdorf AG (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4727657-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM, TERPINENES AND TERPINEOL | Beiersdorf AG (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-3437627-B2 | 2-PROPYLHEPTYLOCTANOAT IN COSMETIC PREPARATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | claimed |
| WO-2024256180-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM AND ACETATES | BEIERSDORF AG (DE) | 2024-12-19 | — | — | WO | claimed |
| WO-2024256181-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM, TERPINENES AND TERPINEOL | BEIERSDORF AG (DE) | 2024-12-19 | — | — | WO | claimed |
| WO-2024256182-A1 | COSMETIC PREPARATION CONTAINING XANTHAN GUM AND VANILLIN DERIVATIVES | BEIERSDORF AG (DE) | 2024-12-19 | — | — | WO | claimed |
| EP-4017598-A1 | COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN AND LIPOPHILIC UV FILTER SUBSTANCES | Beiersdorf AG (DE) | 2022-06-29 | — | — | EP | claimed |
| EP-4017467-A1 | COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN | Beiersdorf AG (DE) | 2022-06-29 | — | — | EP | claimed |
| EP-3962433-A1 | COSMETIC OIL-IN-WATER EMULSION CONTAINING SCLEROGLUCANE | Beiersdorf AG (DE) | 2022-03-09 | — | — | EP | claimed |
| EP-3962435-A1 | COSMETIC O/W EMULSION WITH SCLEROGLUCAN AND LIPOPHILIC UV FILTER SUBSTANCES | Beiersdorf AG (DE) | 2022-03-09 | — | — | EP | claimed |
| EP-3723707-A1 | SUNSCREEN WITH A REDUCED TENDENCY TO STAIN TEXTILES | Beiersdorf AG (DE) | 2020-10-21 | — | — | EP | claimed |
| EP-3072499-B1 | OCTOCRYLENE-FREE SUNSCREEN WITH LOW ADHESION | BEIERSDORF AG (DE) | 2019-07-17 | — | — | EP | claimed |
| EP-2907497-B1 | Cosmetic emulsifier combination | BEIERSDORF AG (DE) | 2019-07-03 | — | — | EP | claimed |
| EP-2185123-B2 | NOVEL COSMETIC EMULSIFIER COMBINATION | BEIERSDORF AG (DE) | 2019-03-20 | — | — | EP | claimed |
| EP-2905012-B1 | Octocrylene-free sunscreen with low adhesion | BEIERSDORF AG (DE) | 2018-04-18 | — | — | EP | claimed |
| EP-2185123-B1 | NOVEL COSMETIC EMULSIFIER COMBINATION | BEIERSDORF AG (DE) | 2015-11-18 | — | — | EP | claimed |
| US-20150209259-A1 | OCTOCRYLENE-FREE SUNSCREEN COMPOSITION WITH LOW STICKINESS | BEIERSDORF AG (DE) | 2015-07-30 | — | — | US | claimed |
| US-20130266621-A1 | STABLE COSMETIC PREPARATION WITH A HIGH PIGMENT CONTENT | BEIERSDORF AG (DE) | 2013-10-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130266621-A1 | STABLE COSMETIC PREPARATION WITH A HIGH PIGMENT CONTENT | TYR, MITF, MC1R | CA2 4616/4885CA1 4839/4885GPR84 4072/4885 |
| US-20150209259-A1 | OCTOCRYLENE-FREE SUNSCREEN COMPOSITION WITH LOW STICKINESS | CUTA, TYR, TTI2 | CA2 2840/4885CA1 4828/4885GPR84 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.